Dysregulation of dynorphins in Alzheimer disease
Authors:
- Z. MarinovaZMZ. Marinova
- A. KuzminAKA. Kuzmin
- N.G. SeidahNSN.G. Seidah
- V. HaroutunianVHV. Haroutunian
- L. TereniusLTL. Terenius
- G. BakalkinGBG. Bakalkin
- 1 November 2007
- journal article
- research article
- Published by Elsevier in Neurobiology of Aging
- Vol. 28 (11) , 1700-1708
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Membrane leakage induced by dynorphinsFEBS Letters, 2006
- Ancient and Recent Positive Selection Transformed Opioid cis-Regulation in HumansPLOS Biology, 2005
- Natural oligomers of the amyloid-β protein specifically disrupt cognitive functionNature Neuroscience, 2004
- A novel soluble protein factor with non-opioid dynorphin A-binding activityBiochemical and Biophysical Research Communications, 2004
- Taurine prevents the neurotoxicity of β‐amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disordersThe FASEB Journal, 2004
- Structure–Activity Analysis of Dynorphin A Toxicity in Spinal Cord Neurons: Intrinsic Neurotoxicity of Dynorphin A and Its Carboxyl-Terminal, Nonopioid MetabolitesExperimental Neurology, 2001
- Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's DiseaseThe American Journal of Pathology, 1999
- 7B2 facilitates the maturation of proPC2 in neuroendocrine cells and is required for the expression of enzymatic activity.Journal of Cell Biology, 1995
- Expression of the neuroendocrine cell marker 7B2 in human ACTH secreting tumoursClinical Endocrinology, 1992
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982